查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1927385

自膨式血管支架市場：依材質、設計、手術、應用、最終用戶和適應症分類－2026-2032年全球預測

Self-Expanding Vascular Stent Market by Material, Design, Procedure Type, Application, End User, Indication - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

自膨式血管支架市場預計到 2025 年將達到 35.5 億美元，到 2026 年將成長到 39.1 億美元，到 2032 年將達到 69.7 億美元，年複合成長率為 10.09%。

關鍵市場統計數據
基準年 2025 35.5億美元
預計年份：2026年 39.1億美元
預測年份 2032 69.7億美元
複合年成長率 (%) 10.09%

本文提供了一個簡潔的自動擴張型支架技術臨床和商業性框架，將器械性能置於現代介入實踐和相關人員期望的背景下進行分析。

在材料科學進步和臨床實踐不斷發展的推動下，自膨式血管支架已成為治療複雜血管疾病的關鍵器械。這些器械利用形狀記憶合金和創新聚合物塗層，可在提供即時血管支撐的同時，適應複雜的血管解剖結構和不同的血管直徑。對於需要動態調節徑向力的解剖結構，以及需要在植入精度和長期血管癒合之間取得平衡的情況，臨床醫生越來越傾向於選擇自膨式支架。因此，器械開發商和醫療系統正在調整產品規格、供應鏈和手術通訊協定，以更好地體現這些植入獨特的機械和生物學特性。

技術創新、流程變革和監管要求的整合如何重塑自膨式血管支架的臨床應用和競爭定位

由於技術創新、手術流程的演變以及醫療體系優先事項的共同作用，自膨式血管支架的市場格局正在經歷變革性變化。合金工程和聚合物科學的進步使得器械具有更優異的貼合性和可控的徑向強度，這正在影響手術方案的選擇和術後管理。同時，混合手術和影像引導手術的興起，正在拓展自膨式器械的應用範圍，使其能夠應用於傳統上難以處理的解剖區域，例如複雜的周邊血管和神經血管區域。這些發展正在重塑臨床路徑，並促使導管檢查室和手術中心製定新的培訓計劃和調整庫存。

評估2025年關稅趨勢對植入式血管器械的採購、製造地和供應連續性的營運和策略影響

2025年的關稅措施和貿易政策調整增加了醫療設備（包括自膨式血管支架）全球供應鏈的複雜性。依賴跨境採購原料合金、特殊聚合物和精密製造設備的製造商面臨成本重新評估和物流調整。進口關稅的提高和合規查核點的增加加重了供應鏈團隊的行政負擔，促使一些公司考慮將關鍵生產過程遷回國內或實現區域供應商多元化。這些策略性供應鏈因應措施優先考慮供應的連續性、可追溯性和對不斷變化的關稅制度的合規性。

對材料科學、臨床應用、設備結構和醫療環境進行多層次分析，可提供細分見解，從而指導優先產品選擇和商業化策略。

細緻的細分分析揭示了臨床需求、材料科學和醫療服務環境之間的交集，從而塑造了產品策略和商業性重點。根據材料，器械可分為鈷鉻合金、鎳鈦合金、聚合物和不銹鋼結構，每種材料在徑向強度、抗疲勞性和影像偽影方面各有優劣，影響臨床選擇。根據應用領域，目標解剖區域涵蓋冠狀動脈、神經血管和周邊血管。冠狀動脈領域進一步涵蓋分叉病變、慢性完全阻塞和支架內血管再阻塞的治療，而神經血管領域則針對動脈瘤治療和中風預防。這顯示解剖結構的複雜性決定了器械的設計和傳輸特性。根據設計，支架可分為裸金屬支架、塗層支架和藥物釋放型支架，每種設計都會影響臨床結果、抗凝血策略和長期血管重塑。

區域戰略考量旨在協調美洲、歐洲、中東和非洲以及亞太地區不同的法規環境、臨床實踐和採購趨勢。

區域趨勢對開發商和醫療系統的策略重點有顯著影響。在美洲，微創手術的快速普及和完善的報銷機制推動了對兼具手術效率和持續療效的醫療設備的需求。醫療系統在採購決策中強調療效比較和持續的臨床數據，而大型城市醫院的卓越醫療中心則率先採用先進的設計。在歐洲、中東和非洲地區（EMEA），監管碎片化和報銷政策不平衡導致了不同的應用模式。為了在多元化的醫療市場站穩腳跟，製造商必須在有針對性的臨床試驗策略、區域性證據產生和客製化定價模式之間取得平衡。該地區部分市場對成本高度敏感，而有些市場則擁有成熟的醫療服務體系，對高性能醫療器材有著迫切的需求。

透過結合臨床證據產生、生產靈活性和許可授權的策略競爭優勢，在植入式血管器械領域建立永續的差異化優勢。

自動擴張型支架領域的競爭格局取決於臨床證據的深度、產品組合的廣度以及生產和監管能力的靈活性。領導者將迭代式器材設計與完善的上市後監測相結合，形成回饋循環，從而加速器材最佳化並支援差異化的臨床應用。與學術機構和大型臨床試驗中心建立策略聯盟，能夠為新適應症和手術流程改進提供培養箱；而與契約製造和物流專家的合作，則有助於在不損害品質系統的前提下實現地域擴張。與合金、塗層和輸送機制相關的智慧財產權是核心資產，保護並選擇性地授權這些技術的企業能夠在控制研發風險的同時，拓展收入來源。

為協調臨床證據產生、穩健的生產製造和以臨床醫生為中心的商業化，以加速產品應用並維持價值，提出切實可行的跨職能建議。

產業領導者應採取緊密整合的策略，將研發重點與臨床證據的生成、生產韌性和商業化準備工作緊密結合。優先產生可操作的臨床證據，將醫療設備屬性與以患者為中心的療效和營運效率聯繫起來，並設計能夠產生可操作見解的研究方案，以引起支付方和採購團隊的共鳴。同時，投資多元化的供應鏈和區域性生產方案，以降低貿易政策變化帶來的風險，並確保高頻手術的短期供應可靠性。將品質源自於設計 (QbD) 原則融入開發平臺，將縮短監管核准時間，並提高不同製造地的產品一致性。

一項結合臨床醫生訪談、技術文獻綜述和供應鏈圖譜分析的嚴謹混合調查方法，得出了可操作且可複製的結論。

我們的研究途徑採用混合方法設計，結合了全面的文獻綜述、對臨床專家的訪談以及供應商生態系統分析，以從技術、臨床和商業性三個層面進行三角驗證。主要定性資料包括對介入性心臟病專家、介入神經放射學專家、血管外科醫師和採購主管的深度訪談，旨在了解他們對器械性能、手術偏好和採購促進因素的實際觀點。從這些訪談中提取的主題編碼識別出反覆出現的挑戰，包括實施障礙、設計權衡和證據缺口。次要研究整合了同行評審文獻、監管指導文件和器械標籤，以檢驗技術聲明並將產品性能屬性與臨床終點相匹配。

本文簡明扼要地總結了在自動擴張型支架技術領域競爭的組織所面臨的臨床、技術和商業性方面的策略要務。

自膨式血管支架處於材料科學、介入技術和醫療系統經濟的關鍵交叉領域。該技術的發展軌跡受到合金和塗層的持續改進、拓展臨床應用的流程創新以及整個治療路徑中對可驗證價值的商業性壓力等因素的影響。希望在該領域主導的相關人員必須整合高品質的臨床證據、供應鏈韌性以及以臨床醫生為中心的商業化策略，以實現永續的應用。不斷變化的監管預期和支付方日益嚴格的審查進一步凸顯了生命週期數據和真實世界性能監測的重要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 自膨式血管支架市場（依材料分類）

  • 鈷鉻
  • 鎳鈦諾
  • 聚合物
  • 不銹鋼

9. 自膨式血管支架市場（依設計分類）

  • 裸金屬
  • 覆蓋類型
  • 藥物釋放型型

10. 自膨式血管支架市場（依手術類型分類）

  • 腹部主動脈血管瘤修復
  • 頸動脈置入術
  • 股動脈置入術
  • 髂動脈置入術

第11章 自膨式血管支架市場（按應用領域分類）

  • 冠狀動脈
    • 分叉病變
    • 慢性完全閉塞
    • 支架內血管再阻塞
  • 神經血管
    • 動脈瘤
    • 預防中風
  • 外圍

12. 自膨式血管支架市場（依最終用戶分類）

  • 門診手術中心
  • 心臟中心
  • 醫院

13. 自膨式血管支架市場依適應症分類

  • 動脈瘤治療
  • 動脈粥狀硬化

14. 各地區自膨式血管支架市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

15. 自膨式血管支架市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國自膨式血管支架市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

17. 美國自膨式血管支架市場

第18章：中國自膨式血管支架市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • Beijing Lepu Medical Technology Co., Ltd.
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Stryker Corporation
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-4F7A6D4FF38D

The Self-Expanding Vascular Stent Market was valued at USD 3.55 billion in 2025 and is projected to grow to USD 3.91 billion in 2026, with a CAGR of 10.09%, reaching USD 6.97 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 3.55 billion
Estimated Year [2026] USD 3.91 billion
Forecast Year [2032] USD 6.97 billion
CAGR (%) 10.09%

A concise clinical and commercial framing of self-expanding stent technology that situates device performance within contemporary interventional practice and stakeholder expectations

Self-expanding vascular stents have emerged as pivotal devices in the management of complex vascular pathologies, driven by material science advances and evolving clinical practices. These devices leverage shape-memory alloys and innovative polymer coatings to provide immediate vessel scaffolding while accommodating tortuous anatomies and variable vessel diameters. Clinicians increasingly prefer self-expanding designs for anatomies where radial force needs dynamic adaptation and where deployment precision must balance with long-term vessel healing. As a result, device developers and health systems are recalibrating product specifications, supply chains, and procedural protocols to reflect the distinctive mechanical and biological interactions of these implants.

The technology's maturation intersects with broader shifts in minimally invasive care, regulatory oversight, and reimbursement pathways. Manufacturers face elevated demands for biocompatibility, imaging compatibility, and long-term durability evidence, while interventional specialists press for thinner profiles, enhanced deliverability, and adjunctive drug-eluting options to reduce restenosis risk. Concurrently, supply chain resilience and quality management systems have become non-negotiable as OEMs scale production and prepare for expanded clinical indications. This introduction establishes the clinical rationale and commercial logic that underpin the subsequent analysis and sets expectations for the evidence, stakeholder behaviors, and strategic responses explored in the full report.

How converging technological advances, procedural shifts, and regulatory expectations are reshaping clinical adoption and competitive positioning for self-expanding vascular stents

The landscape for self-expanding vascular stents is experiencing transformative shifts driven by converging technological innovation, procedural evolution, and health system priorities. Advances in alloy engineering and polymer science have enabled devices with superior conformability and controlled radial strength, which in turn are influencing procedural selection and post-procedural management. Simultaneously, the rise of hybrid and image-guided interventions has expanded the role of self-expanding devices into anatomies previously considered challenging, such as complex peripheral and neurovascular territories. These developments are reshaping clinical pathways, requiring new training modules and altered inventory profiles in catheterization laboratories and surgical centers.

Payer dynamics and value-based procurement models are also prompting manufacturers to invest in evidence generation that links device attributes to measurable downstream outcomes, including reduced reinterventions and shorter hospital stays. At the same time, regulatory authorities are emphasizing real-world performance and lifecycle data, which encourages iterative design improvements and post-market surveillance investments. This combination of technological progress, procedural innovation, and regulatory evolution creates a dynamic environment where agility in clinical evidence generation and manufacturing scalability becomes a competitive differentiator.

Assessing the operational and strategic consequences of 2025 tariff developments on sourcing, manufacturing footprints, and supply continuity for implantable vascular devices

Tariff actions and trade policy adjustments in 2025 introduced a layer of complexity into global supply dynamics for medical devices, including self-expanding vascular stents. Manufacturers that rely on cross-border sourcing for raw alloys, specialized polymers, or precision manufacturing equipment faced cost re-evaluations and logistics recalibrations. Import duties and compliance checkpoints increased the administrative burden for supply chain teams, prompting some firms to consider reshoring critical production steps or to diversify supplier bases regionally. These strategic supply chain responses prioritized continuity of supply, traceability, and compliance with evolving customs regimes.

Clinicians and procurement teams experienced downstream effects through altered delivery lead times and revised inventory strategies. Health systems that operate within tightly managed capital frameworks confronted decisions about buffer stock levels and vendor consolidation to mitigate exposure to tariff volatility. In parallel, manufacturers accelerated conversations with contract manufacturers and logistics partners to negotiate terms that balance predictability with cost-efficiency. The combined impact of tariffs and trade shifts therefore underscored the importance of flexible manufacturing footprints, robust supplier qualification processes, and scenario-based sourcing strategies to preserve clinical availability while managing commercial pressures.

Layered segmentation insights that map material science, clinical application, device architecture, and care settings to prioritized product and commercialization choices

A nuanced segmentation analysis reveals where clinical needs, material science, and care delivery settings intersect to shape product strategies and commercial focus. Based on material, devices are differentiated by Cobalt-Chromium, Nitinol, Polymer, and Stainless Steel constructions-each offering distinct trade-offs in terms of radial strength, fatigue resistance, and imaging artifact profiles that influence clinical selection. Based on application, target anatomies span Coronary, Neurovascular, and Peripheral territories; the Coronary application further encompasses treatment for bifurcation lesions, chronic total occlusion, and in-stent restenosis, while Neurovascular use targets aneurysm treatment and stroke prevention, illustrating how anatomical complexity dictates design and delivery characteristics. Based on design, stents present as bare metal, covered, or drug eluting platforms, with each design class carrying implications for clinical outcomes, anticoagulation strategies, and long-term vessel remodeling.

Based on end user, procurement and utilization differ across ambulatory surgical centers, cardiac centers, and hospitals, with site-specific purchasing protocols, inventory capacities, and clinical staffing that influence product adoption. Based on indication, the primary clinical objectives bifurcate into aneurysm treatment and management of atherosclerotic disease, driving divergent evidence requirements and follow-up regimens. Based on procedure type, clinical workflows and device specifications vary across abdominal aortic aneurysm repair, carotid artery stenting, femoral artery stenting, and iliac artery stenting, each procedure category imposing unique constraints on delivery system profile, radiopacity, and navigability. Understanding these layered dimensions enables manufacturers and clinicians to align design priorities, training programs, and commercial approaches with the real-world contexts in which these devices are selected and used.

Regional strategic considerations that reconcile diverse regulatory realities, clinical practices, and procurement dynamics across the Americas, EMEA, and Asia-Pacific

Regional dynamics materially influence strategic priorities for developers and health systems. In the Americas, rapid adoption of minimally invasive interventions and established reimbursement pathways drive demand for devices that demonstrate procedural efficiency and durable outcomes. Health systems emphasize comparative effectiveness and durable clinical data to inform procurement, while centers of excellence in major urban hospitals function as early adopters for advanced designs. In Europe, Middle East & Africa, regulatory fragmentation and heterogeneous reimbursement policies create a mosaic of adoption patterns; manufacturers must balance centralized trial strategies with localized evidence generation and tailored pricing models to gain traction across diverse healthcare markets. In this region, cost sensitivity in some markets coexists with pockets of sophisticated care delivery that demand high-performance devices.

In the Asia-Pacific region, rapid expansion of interventional capacity, growing incidence of vascular disease, and investments in domestic manufacturing are reshaping competitive dynamics. Local regulatory pathways are evolving, and strategic partnerships with regional clinical leaders accelerate adoption. Across all regions, differences in clinical practice patterns, reimbursement structures, and supply chain resilience necessitate differentiated go-to-market approaches that account for regulatory timelines, local clinical champions, and procurement behaviors. Success in any region depends on harmonizing clinical evidence, operational readiness, and culturally informed engagement with key stakeholders.

Strategic competitive levers that combine clinical evidence generation, manufacturing agility, and platform licensing to establish durable differentiation in implantable vascular devices

Competitive dynamics in the self-expanding stent space are driven by the depth of clinical evidence, breadth of device portfolios, and the agility of manufacturing and regulatory capabilities. Leading firms that integrate iterative device design with robust post-market surveillance create a feedback loop that accelerates device optimization and supports differentiated clinical claims. Strategic partnerships with academic centers and high-volume clinical sites serve as incubators for novel indications and procedural refinements, while collaborations with contract manufacturers and logistics specialists enable geographic expansion without compromising quality systems. Intellectual property around alloys, coatings, and delivery mechanisms remains a core asset, and firms that protect and selectively license these technologies can expand revenue streams while managing development risk.

At the same time, competitive advantage accrues to organizations that can demonstrate reproducible clinical outcomes across diverse patient cohorts and procedural contexts. Companies that invest in clinician training, simulation platforms, and comprehensive device support systems lower adoption barriers and shorten learning curves. Finally, entrants that leverage modular platform strategies-where a common delivery system supports multiple stent types or indications-can scale more efficiently and respond to clinician feedback without protracted redevelopment cycles. These strategic levers collectively define a competitive playbook for firms seeking durable differentiation in a space characterized by rapid clinical and technological evolution.

Actionable cross-functional recommendations that synchronize clinical evidence generation, resilient manufacturing, and clinician-focused commercialization to accelerate adoption and sustain value

Industry leaders should pursue a tightly integrated strategy that aligns R&D priorities with clinical evidence generation, manufacturing resilience, and commercial readiness. Prioritize generating pragmatic clinical evidence that connects device attributes to patient-centered outcomes and operational efficiencies, and structure studies to produce actionable insights that resonate with payers and procurement teams. Concurrently, invest in diversified supply chains and regional manufacturing options to mitigate exposure to trade policy shifts and to ensure near-term delivery reliability for high-volume procedures. Embedding quality-by-design principles into development pipelines will reduce time to regulatory acceptance and improve product consistency across production sites.

Commercial organizations should adopt clinician-centered engagement programs that combine hands-on training with outcome-monitoring support to facilitate adoption in both specialty cardiac centers and ambulatory settings. Consider modular platform approaches that enable faster introduction of incremental innovations without rebuilding core delivery systems. Finally, create cross-functional capabilities that translate post-market evidence into compelling value narratives for hospital administrators and health systems, focusing on total cost of care, patient throughput advantages, and reduced reintervention burdens. This integrated approach will position leaders to capture clinical trust and to sustain commercial momentum as procedural paradigms evolve.

A rigorous mixed-methods research framework combining clinician interviews, technical literature synthesis, and supply chain mapping to produce actionable and reproducible insights

The research approach relied on a mixed-methods design that combined comprehensive literature appraisal, expert clinician interviews, and supplier ecosystem mapping to triangulate insights across technical, clinical, and commercial domains. Primary qualitative inputs included in-depth interviews with interventional cardiologists, neurointerventional specialists, vascular surgeons, and procurement leaders to capture frontline perspectives on device performance, procedural preferences, and purchasing drivers. These conversations informed thematic coding that identified recurring adoption barriers, design trade-offs, and evidence gaps. Secondary research synthesized current peer-reviewed literature, regulatory guidance documents, and device labeling to validate technical claims and to align product performance attributes with clinical endpoints.

Supply chain assessments incorporated structured reviews of manufacturing footprints, materials sourcing dependencies, and logistics constraints to evaluate operational risk points. Regulatory pathway analysis focused on the procedural and data expectations across major jurisdictions, while clinical evidence mapping highlighted where post-market studies could meaningfully de-risk adoption. The methodology emphasized transparency and reproducibility, documenting data sources, interview protocols, and analytic assumptions to enable clients to trace the evidence that supports each insight. The mixed-methods approach ensures that strategic recommendations rest on convergent evidence from practitioners, technical documentation, and operational analysis.

Concise synthesis of clinical, technical, and commercial imperatives that define the strategic path for organizations competing in self-expanding stent technologies

Self-expanding vascular stents occupy a pivotal intersection of material science, interventional technique, and health system economics. The technology's trajectory is shaped by continuous improvements in alloys and coatings, by procedural innovations that expand clinical applications, and by commercial pressures that demand demonstrable value across care pathways. Stakeholders seeking to lead in this space must integrate high-quality clinical evidence, supply chain resilience, and clinician-centered commercialization to build durable adoption. The evolution of regulatory expectations and payer scrutiny further elevates the importance of lifecycle data and real-world performance monitoring.

In sum, the pathway to sustained success requires coordinated investments across product development, evidence generation, manufacturing operations, and market access. Organizations that align these components with clearly articulated clinical and economic narratives will find the greatest opportunities to differentiate, to support clinician confidence, and to deliver patient-centered outcomes. The subsequent full report expands on these themes with detailed clinical profiles, device-level comparisons, procedural workflow implications, and a prioritized set of strategic initiatives designed to guide decision makers through near- and medium-term choices.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Self-Expanding Vascular Stent Market, by Material

  • 8.1. Cobalt-Chromium
  • 8.2. Nitinol
  • 8.3. Polymer
  • 8.4. Stainless Steel

9. Self-Expanding Vascular Stent Market, by Design

  • 9.1. Bare Metal
  • 9.2. Covered
  • 9.3. Drug Eluting

10. Self-Expanding Vascular Stent Market, by Procedure Type

  • 10.1. Abdominal Aortic Aneurysm Repair
  • 10.2. Carotid Artery Stenting
  • 10.3. Femoral Artery Stenting
  • 10.4. Iliac Artery Stenting

11. Self-Expanding Vascular Stent Market, by Application

  • 11.1. Coronary
    • 11.1.1. Bifurcation Lesions
    • 11.1.2. Chronic Total Occlusion
    • 11.1.3. In-Stent Restenosis
  • 11.2. Neurovascular
    • 11.2.1. Aneurysm
    • 11.2.2. Stroke Prevention
  • 11.3. Peripheral

12. Self-Expanding Vascular Stent Market, by End User

  • 12.1. Ambulatory Surgical Center
  • 12.2. Cardiac Center
  • 12.3. Hospital

13. Self-Expanding Vascular Stent Market, by Indication

  • 13.1. Aneurysm Treatment
  • 13.2. Atherosclerosis

14. Self-Expanding Vascular Stent Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Self-Expanding Vascular Stent Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Self-Expanding Vascular Stent Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Self-Expanding Vascular Stent Market

18. China Self-Expanding Vascular Stent Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. B. Braun Melsungen AG
  • 19.7. Becton, Dickinson and Company
  • 19.8. Beijing Lepu Medical Technology Co., Ltd.
  • 19.9. Boston Scientific Corporation
  • 19.10. Cook Group Incorporated
  • 19.11. Medtronic plc
  • 19.12. Meril Life Sciences Pvt. Ltd.
  • 19.13. MicroPort Scientific Corporation
  • 19.14. Stryker Corporation
  • 19.15. Terumo Corporation
  • 19.16. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COBALT-CHROMIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NITINOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BARE METAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COVERED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DRUG ELUTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ABDOMINAL AORTIC ANEURYSM REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CAROTID ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY FEMORAL ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ILIAC ARTERY STENTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY BIFURCATION LESIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CHRONIC TOTAL OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY IN-STENT RESTENOSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY STROKE PREVENTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CARDIAC CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ANEURYSM TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 84. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 86. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 87. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 89. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 90. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 91. AMERICAS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 99. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 100. NORTH AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 107. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 108. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 109. LATIN AMERICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 116. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 117. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 128. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 130. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 131. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 132. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 137. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 139. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 140. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 156. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 157. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 158. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 165. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 167. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 168. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 171. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 172. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. GCC SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. BRICS SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 192. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 194. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 195. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 198. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 199. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. G7 SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 201. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 203. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 204. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 207. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 208. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. NATO SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED STATES SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY DESIGN, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY CORONARY, 2018-2032 (USD MILLION)
  • TABLE 226. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY NEUROVASCULAR, 2018-2032 (USD MILLION)
  • TABLE 227. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. CHINA SELF-EXPANDING VASCULAR STENT MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)